Want to see JP:4461 full AI Analyst Report?
DKS Co., Ltd. (4461) Stock Price & Analysis
4461 Stock Chart & Stats
- Day’s Range
- JPY 9,710.00 - JPY 10,400.00
- 52-Week Range
- JPY 6,330.00 - JPY 17,240.00
- Previous Close
- JPY 10,180.00
- Volume
- N/A
- Average Volume (3M)
- 300.81K
- Market Cap
- JPY 107.72B
- Enterprise Value
- JPY 163.65B
- Total Cash (Recent Filing)
- JPY 21.06B
- Total Debt (Recent Filing)
- JPY 27.44B
- Price to Earnings (P/E)
- 11.7
- Beta
- 1.67
- Next Earnings
- Jan 28, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 1.63%
Bulls Say, Bears Say
Bulls Say
Revenue And Margin Recovery
The 2026 improvement in revenue growth and profitability indicates stronger pricing, product mix, or operating leverage. If sustained, higher margins can improve earnings resilience, support internal investment, and strengthen the company’s ability to compete through the next several quarters.
Improved Balance Sheet Leverage
Lower leverage and a larger equity base improve financial flexibility after the earnings recovery. A debt-to-equity ratio of about 0.56 reduces balance-sheet pressure relative with prior years, giving management more capacity to fund operations and withstand weaker profitability.
Recent Free Cash Flow Generation
Positive free cash flow across 2025 and 2026, with meaningful conversion from net income, supports the quality of the recent earnings rebound. This internally generated cash can help service debt, fund investment, and reduce reliance on external financing over the medium term.
Bears Say
Earnings Volatility
The swing from a 2023 loss and weaker 2024–2025 margins to a strong 2026 result shows that profitability has not yet demonstrated consistent through-cycle stability. Such volatility makes future earnings less predictable and can complicate durable capital allocation planning.
Uneven Cash Conversion
Recent free cash flow is encouraging, but modest operating cash flow relative to revenue and the weak 2023 outcome indicate that cash generation can vary materially. Sensitivity to working-capital swings or investment cycles may limit the reliability of internally funded growth.
Meaningful Debt Exposure
Although leverage improved in 2026, approximately ¥29B of total debt remains a material obligation, and the historical rise in leverage during weaker profitability highlights ongoing balance-sheet sensitivity. A future earnings downturn could again constrain financial flexibility and cash deployment.
DKS Co., Ltd. News
4461 FAQ
What was DKS Co., Ltd.’s price range in the past 12 months?
What is DKS Co., Ltd.’s market cap?
When is DKS Co., Ltd.’s upcoming earnings report date?
How were DKS Co., Ltd.’s earnings last quarter?
Is DKS Co., Ltd. overvalued?
Does DKS Co., Ltd. pay dividends?
What is DKS Co., Ltd.’s EPS estimate?
How many shares outstanding does DKS Co., Ltd. have?
What happened to DKS Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of DKS Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
DKS Co., Ltd.
Headquartered in Kyoto, Japan, DKS Co. Ltd. is a global producer and purveyor of a diverse range of industrial chemicals and surfactants, serving numerous industries worldwide. The company’s operations are organized into six distinct segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electronic Device Materials, and Life Sciences. Within its Surfactants division, DKS develops various types such as nonionic, anionic, cationic, polymerizable, and amphoteric compounds, in addition to specialized surfactant blends. The Amenity Materials segment features products like sucrose fatty acid esters, sodium carboxymethyl celluloses, cellulose nanofibers and other polymers, polyvinyl pyrrolidone, polyacrylamide and polyacrylate, and industrial deodorizers. Its Polyurethane Materials offerings include polyether polyols, urethane prepolymers, and comprehensive urethane systems. For Functional Materials, DKS manufactures radiation-curable monomers and oligomers, waterborne polyurethanes, flame retardants, and amide-based lubricants. The Electronic Device Materials group supplies ionic liquids, ion-conductive polymers, ceramic/metal injection molding components, conductive pastes for electronic applications, injection molding pellets, and advanced inorganic materials. Furthermore, the Life Sciences segment crafts health and dietary supplements, notably an I. Japonica-Bombyx Fungus product and Sudachin, a distinct citrus peel extract powder. Founded in 1909, the firm was formerly known as Dai-ichi Kogyo Seiyaku Co., Ltd. before rebranding to DKS Co. Ltd. in 2013.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Naoki Yamaji
- Employees
- 23,830
- Website
- www.dks-web.co.jp
- Address
- 48-2 Higashikujo-Kamitonodacho, Kyoto, KY, 601-8002, JP
DKS Co., Ltd. (4461) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 4 | 14 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 0 | 0 | 12 |








